Provided by Tiger Trade Technology Pte. Ltd.

Surmodics

42.98
0.0000
Volume:- -
Turnover:228.42M
Market Cap:614.51M
PE:-34.66
High:42.98
Open:42.98
Low:42.98
Close:42.98
52wk High:43.00
52wk Low:25.87
Shares:14.30M
Float Shares:12.27M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2402
EPS(LYR):-0.8155
ROE:-15.36%
ROA:-0.52%
PB:5.52
PE(LYR):-52.70

Loading ...

Press Release: Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR

Dow Jones
·
Nov 11, 2025

Surmodics acquisition by GTCR can proceed, Reuters reports

TIPRANKS
·
Nov 11, 2025

US judge rejects FTC's bid to block private equity medical company deal

Reuters
·
Nov 11, 2025

U.S. Court Denies U.S. Federal Trade Commission's Bid to Block Gtcr's Acquisition of Surmodics – Court Hearing

THOMSON REUTERS
·
Nov 11, 2025

Surmodics Shares Halted for News Pending; Last up 2.1% at $27.34

THOMSON REUTERS
·
Nov 11, 2025

SurModics trading halted, news pending

TIPRANKS
·
Nov 11, 2025

BRIEF-Surmodics Shares Data From 160 Patients In PROWL Registry Using Pounce For Real-World Limb Ischemia

Reuters
·
Nov 04, 2025

Surmodics Reports High Success Rates for Pounce Thrombectomy Device in Real-World Limb Ischemia Study

Reuters
·
Nov 04, 2025

Surmodics Inc - Device Technical Success 83.2% With <50% Residual Obstruction

THOMSON REUTERS
·
Nov 04, 2025

Surmodics Inc - Procedural Success 91.7%, Device-Related Adverse Events 0.6%

THOMSON REUTERS
·
Nov 04, 2025

Surmodics Inc - 94.8% Patients Experienced Post-Procedural Blood Flow Restoration

THOMSON REUTERS
·
Nov 04, 2025

Surmodics Announces Outcomes From 160 Patients in Prowl Registry Evaluating Pounce™ Thrombectomy Platform in Treatment of Real-World Limb Ischemia Presentations

THOMSON REUTERS
·
Nov 04, 2025

SurModics Unveils Positive PROWL Registry Data on Pounce Thrombectomy Platform at VIVA Conference

Reuters
·
Nov 03, 2025

Surmodics announces results from PROWL registry study

TIPRANKS
·
Oct 30, 2025

SurModics Unveils Sex-Specific Results for Pounce Thrombectomy Device in PROWL Registry Study

Reuters
·
Oct 28, 2025

Surmodics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 08, 2025

Surmodics Q3 EPS USD -0.37

Reuters
·
Aug 08, 2025

Surmodics Q3 Adj. EPS $0.06 Beats $(0.19) Estimate, Sales $29.567M Beat $28.055M Estimate

Benzinga
·
Aug 08, 2025

SurModics Inc. Reports Q3 FY 2025 Revenue Decrease of 3%, GAAP Loss Narrows to $5.3 Million; Adjusted EBITDA Rises to $3.4 Million

Reuters
·
Aug 08, 2025

Surmodics Q3 Pretax Profit USD -5.929 Million

THOMSON REUTERS
·
Aug 08, 2025